Ask AI
Martin J. Abrahamson

Martin J. Abrahamson, MD, FACP

Associate Professor of Medicine
Harvard Medical School
Director, Division of CME
Department of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Explore Activities by Martin J. Abrahamson

Title
Format
Credit Type
Credits
توسيع نطاق خيارات العلاج لمرض السكري من النوع الثاني وزيادة الوزن/السمنة: أبرز ما جاء في الاجتماع السنوي للجمعية الأمريكية للسكري لعام 2025

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Erweiterung der Behandlungsmöglichkeiten für Typ-2-Diabetes und Übergewicht/Fettleibigkeit: Höhepunkte der 2025 ADA Jahrestagung

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Ampliamento delle opzioni di trattamento per il diabete di tipo 2 e il sovrappeso/l'obesità: Momenti salienti del convegno annuale dell'ADA del 2025

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
扩大 2 型糖尿病以及超重/肥胖患者的治疗方案:2025 年 ADA 年会的亮点内容

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expandir as opções de tratamento para diabetes tipo 2 e Excesso de Peso/Obesidade: Destaques da Reunião Anual da ADA de 2025

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
2型糖尿病の治療選択肢の拡大と過体重・肥満:2025年ADA年次総会のハイライト

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Élargir les options de traitement pour le diabète de type 2 et le surpoids/l'obésité : Faits marquants de la réunion annuelle de l'ADA 2025

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Ampliación de las opciones de tratamiento para la diabetes tipo 2 y sobrepeso u obesidad: Aspectos destacados de la Junta Anual de la ADA de 2025

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expanding Treatment Options for Type 2 Diabetes and Overweight/Obesity: Highlights From the 2025 ADA Annual Meeting

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

0.25
Experts on the Ground: ​Independent Conference Coverage of ADA 2024

Content Format:

Video

Credit Type:

AAPA | AMA | ANCC

Credits:

0.50
Insights From the Field: Expert Commentary on ADA 2024 Highlights

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Experts on the Ground: Independent Conference Coverage of ADA 2024

Content Format:

Slideset

Credit Type:

--

Credits:

--
Shifting the Treatment Paradigm of Weight Management and Type 2 Diabetes in Primary Care: Interactive Case Challenge 2

Content Format:

Case Challenge

Credit Type:

AAPA | ABIM MOC | AMA | ANCC

Credits:

1.00
Shifting the Treatment Paradigm of Weight Management and Type 2 Diabetes in Primary Care

Content Format:

Slideset

Credit Type:

--

Credits:

--
Shifting the Treatment Paradigm of Weight Management and Type 2 Diabetes in Primary Care: Interactive Case Challenge 1

Content Format:

Case Challenge

Credit Type:

AAPA | ABIM MOC | AMA | ANCC

Credits:

1.00
Live Interactive Case Challenge: Shifting the Treatment Paradigm of Weight Management and T2D in Primary Care

Content Format:

Case Challenge

Credit Type:

--

Credits:

--
Shifting the Treatment Paradigm of Weight Management and Type 2 Diabetes in Primary Care

Content Format:

Slideset

Credit Type:

--

Credits:

--
Shifting the Treatment Paradigm of Weight Management and Type 2 Diabetes in Primary Care

Content Format:

Slideset

Credit Type:

--

Credits:

--
Impact of the 2022 ADA/EASD Consensus Statement on the Management of T2D

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
The Internist’s Approach to Leveraging Continuous Glucose Monitoring in Diabetes

Content Format:

Multimedia

Credit Type:

AAPA | AMA | ANCC

Credits:

1.00
The Internist’s Approach to Leveraging Continuous Glucose Monitoring in Diabetes

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
ADA 2021: Key Studies Influencing Diabetes Care

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.50
How New Phase III Data From ADA 2021 Could Affect Your Diabetes Practice

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Diabetes Consult: Selecting T2D Treatments for High-Risk Patients

Content Format:

Tool

Credit Type:

AMA | ANCC

Credits:

0.25
How I Use SGLT2 Inhibitors in T2D for Cardiovascular and Renal Disease

Content Format:

Clinical Thought

Credit Type:

AMA | ANCC

Credits:

0.25
How I Address Adverse Events With My Patients Receiving GLP-1 Receptor Agonists

Content Format:

Clinical Thought

Credit Type:

AMA | ANCC

Credits:

0.25
Choosing Among GLP-1 Receptor Agonists for Patients With Type 2 Diabetes

Content Format:

Tool

Credit Type:

AMA | ANCC

Credits:

0.25